See more : Uxin Limited (UXIN) Income Statement Analysis – Financial Results
Complete financial analysis of Oxurion NV (OXUR.BR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oxurion NV, a leading company in the Biotechnology industry within the Healthcare sector.
- JZ Capital Partners Limited (JZCP.L) Income Statement Analysis – Financial Results
- Gold Basin Resources Corporation (GXXFF) Income Statement Analysis – Financial Results
- Vanguard International Semiconductor Corporation (5347.TWO) Income Statement Analysis – Financial Results
- Myriad Metals Corp. (MMC.CN) Income Statement Analysis – Financial Results
- EMV Capital plc (EMVC.L) Income Statement Analysis – Financial Results
Oxurion NV (OXUR.BR)
About Oxurion NV
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 263.00K | 595.00K | 1.13M | 2.08M | 3.95M | 5.32M | 5.81M | 7.10M | 11.20M | 13.78M | 112.78M | 75.08M | 2.48M | 6.18M | 4.21M | 30.42M | 1.25M | 3.24M |
| Cost of Revenue | 159.00K | 866.00K | 1.29M | 1.66M | 5.03M | 3.36M | 2.58M | 6.88M | 3.23M | 4.60M | 6.38M | 3.15M | 216.00K | 540.00K | 270.00K | 2.75M | 168.00K | 1.21M |
| Gross Profit | 104.00K | -271.00K | -161.00K | 419.00K | -1.09M | 1.97M | 3.23M | 224.00K | 7.97M | 9.18M | 106.40M | 71.94M | 2.26M | 5.64M | 3.94M | 27.67M | 1.08M | 2.03M |
| Gross Profit Ratio | 39.54% | -45.55% | -14.27% | 20.16% | -27.52% | 36.94% | 55.61% | 3.15% | 71.16% | 66.61% | 94.34% | 95.81% | 91.28% | 91.26% | 93.59% | 90.97% | 86.58% | 62.60% |
| Research & Development | 9.99M | 15.68M | 20.20M | 21.58M | 23.74M | 29.60M | 24.01M | 24.71M | 22.96M | 23.86M | 35.09M | 20.05M | 19.68M | 18.68M | 19.48M | 15.71M | 17.23M | 8.12M |
| General & Administrative | 2.82M | 5.98M | 7.15M | 5.49M | 6.32M | 6.35M | 6.23M | 6.52M | 7.95M | 9.52M | 11.58M | 5.84M | 5.88M | 3.64M | 3.74M | 3.03M | 2.32M | 1.24M |
| Selling & Marketing | -142.00K | 892.00K | 1.27M | 3.25M | 6.96M | 6.22M | 4.25M | 4.33M | 17.65M | 29.87M | 37.62M | 13.37M | 5.56M | 1.82M | 462.00K | 493.00K | 413.00K | 26.00K |
| SG&A | 2.68M | 6.82M | 8.33M | 8.60M | 13.08M | 12.57M | 10.47M | 10.85M | 25.59M | 39.39M | 49.20M | 19.21M | 11.44M | 5.45M | 4.20M | 3.52M | 2.73M | 1.26M |
| Other Expenses | -453.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.00K | -4.08M | -3.84M | -4.75M | -1.75M | -1.46M | -74.00K |
| Operating Expenses | 12.21M | 22.51M | 28.53M | 30.17M | 36.82M | 40.89M | 19.36M | 60.77M | 46.25M | 61.13M | 81.39M | 42.86M | 27.03M | 20.30M | 18.93M | 15.34M | 18.50M | 12.46M |
| Cost & Expenses | 12.37M | 23.37M | 29.82M | 31.83M | 41.85M | 44.25M | 21.94M | 67.65M | 49.48M | 65.73M | 87.77M | 46.00M | 27.25M | 20.84M | 19.20M | 18.08M | 18.67M | 13.67M |
| Interest Income | 2.00K | 9.00K | 9.00K | 21.00K | 28.00K | 157.00K | 42.00K | 178.00K | 387.00K | 975.00K | 1.40M | 2.04M | 3.35M | 946.00K | 1.33M | 3.35M | 1.78M | 593.00K |
| Interest Expense | 1.97M | 1.37M | 739.00K | 54.00K | 55.00K | 24.00K | 31.00K | 36.00K | 37.00K | 33.00K | 26.00K | 28.00K | 20.00K | 206.00K | 381.00K | 1.75M | 321.00K | 32.00K |
| Depreciation & Amortization | 268.00K | 353.00K | 677.00K | 1.11M | 2.77M | 3.63M | 3.83M | 7.68M | 7.99M | 8.13M | 7.66M | 668.00K | 382.00K | 426.00K | 490.00K | 1.75M | -33.05M | 1.34M |
| EBITDA | -16.73M | -29.96M | -28.18M | -27.40M | -49.26M | -35.12M | 26.49M | -52.66M | -29.87M | -42.81M | 33.17M | 31.12M | -21.25M | -14.23M | -13.53M | 12.34M | -17.10M | -8.76M |
| EBITDA Ratio | -6,360.84% | -3,769.08% | -2,483.24% | -1,378.49% | -890.32% | -693.74% | -463.72% | -373.94% | -276.19% | -323.64% | 29.42% | 41.48% | -985.06% | -215.19% | -312.63% | 40.55% | -1,248.96% | -270.00% |
| Operating Income | -12.11M | -22.78M | -28.69M | -29.76M | -37.91M | -39.24M | -29.48M | -34.25M | -38.92M | -52.71M | 25.51M | 29.10M | -24.77M | 14.66M | 14.99M | 10.59M | 17.42M | 10.43M |
| Operating Income Ratio | -4,604.56% | -3,828.40% | -2,543.26% | -1,431.91% | -960.59% | -737.61% | -507.38% | -482.09% | -347.54% | -382.65% | 22.62% | 38.76% | -1,000.48% | 237.41% | 355.73% | 34.80% | 1,391.13% | 321.49% |
| Total Other Income/Expenses | -6.86M | -8.74M | -904.00K | 60.00K | -14.18M | 472.00K | -637.00K | 464.00K | 1.03M | 1.74M | 903.00K | 1.35M | 3.14M | 4.58M | 5.69M | 1.60M | 2.92M | 1.07M |
| Income Before Tax | -18.97M | -31.69M | -29.59M | -28.56M | -52.09M | -38.77M | 22.63M | -60.37M | -37.89M | -50.98M | 26.41M | 30.45M | -21.64M | -13.92M | -14.04M | 12.19M | -15.96M | -10.12M |
| Income Before Tax Ratio | -7,211.41% | -5,325.38% | -2,623.40% | -1,374.40% | -1,319.97% | -728.74% | 389.48% | -849.80% | -338.36% | -370.03% | 23.42% | 40.55% | -873.83% | -225.43% | -333.30% | 40.05% | -1,274.60% | -312.18% |
| Income Tax Expense | 3.00K | 7.00K | 3.00K | -548.00K | 17.00K | 10.00K | 14.00K | 22.00K | 42.00K | 140.00K | 13.00K | 34.00K | 1.00K | 22.00K | 28.00K | 90.00K | 9.00K | 10.00K |
| Net Income | -18.97M | -31.69M | -29.16M | -28.01M | -51.83M | -38.47M | 22.79M | -60.31M | -37.88M | -51.12M | 26.40M | 30.42M | -21.64M | -13.94M | -14.07M | 12.10M | -15.97M | -10.13M |
| Net Income Ratio | -7,212.55% | -5,325.21% | -2,584.93% | -1,348.03% | -1,313.41% | -723.20% | 392.22% | -849.01% | -338.31% | -371.04% | 23.41% | 40.51% | -873.87% | -225.78% | -333.97% | 39.76% | -1,275.32% | -312.49% |
| EPS | -0.01 | -3.73K | -0.76 | -0.73 | -1.35 | -1.01 | 0.63 | -1.67 | -1.05 | -1.42 | 0.71 | 0.87 | -0.67 | -0.47 | -0.53 | 0.47 | -0.62 | -0.46 |
| EPS Diluted | -0.01 | -3.73K | -0.76 | -0.73 | -1.35 | -1.01 | 0.62 | -1.67 | -1.05 | -1.42 | 0.71 | 0.84 | -0.65 | -0.46 | -0.51 | 0.45 | -0.62 | -0.46 |
| Weighted Avg Shares Out | 1.65B | 8.50M | 38.41M | 38.29M | 38.29M | 38.09M | 36.09M | 36.09M | 36.08M | 36.00M | 37.18M | 34.95M | 32.41M | 29.38M | 26.46M | 25.64M | 25.91M | 22.14M |
| Weighted Avg Shares Out (Dil) | 1.65B | 8.50M | 38.41M | 38.29M | 38.29M | 38.25M | 36.60M | 36.12M | 36.09M | 36.09M | 36.94M | 36.01M | 33.35M | 30.22M | 27.36M | 26.85M | 25.91M | 22.14M |
Source: https://incomestatements.info
Category: Stock Reports